scispace - formally typeset
N

Nigel A. Cunliffe

Researcher at University of Liverpool

Publications -  195
Citations -  8593

Nigel A. Cunliffe is an academic researcher from University of Liverpool. The author has contributed to research in topics: Rotavirus & Rotavirus vaccine. The author has an hindex of 45, co-authored 188 publications receiving 7822 citations. Previous affiliations of Nigel A. Cunliffe include Public Health England & Malawi-Liverpool-Wellcome Trust Clinical Research Programme.

Papers
More filters
Journal ArticleDOI

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs.

TL;DR: Strain surveillance helps to determine whether the most prevalent local strains are likely to be covered by the serotype antigens found in current vaccines, and identified globally (G9) or regionally (G5, G8, and P2A[6]) common serotypes not cover by the reassortant vaccines that have undergone efficacy trials.
Reference EntryDOI

Vaccines for preventing rotavirus diarrhoea: vaccines in use

TL;DR: Evaluating rotavirus vaccines approved for use (RV1, RV5, and LLR) for preventingRotavirus diarrhoea in children with high-mortality rates found that RV1 probably prevents 40% of severe all-cause diarrhoeA episodes, and RV5probably prevents 40%, based on one large multicentre trial in Latin America and Finland.
Journal Article

Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization.

TL;DR: C cumulative experience from 15 African countries suggests that rotavirus is the most important cause of severe diarrhoea in African children and that most strains in circulation today belong to common G types that are included in reassortant vaccines.
Journal ArticleDOI

Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: Global distribution of genogroups, genotypes and GII.4 variants

TL;DR: A systematic review of studies performed after 2000 to clarify the genotypic distribution of noroviruses in children (≤18 years of age) with sporadic acute gastroenteritis found that Genogroup GII norovirus was the most prevalent, accounting for 96% of all sporadic infections.